649 related articles for article (PubMed ID: 16030108)
1. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
2. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
[TBL] [Abstract][Full Text] [Related]
3. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and endometrial cancer risk: a meta-analysis.
Grady D; Gebretsadik T; Kerlikowske K; Ernster V; Petitti D
Obstet Gynecol; 1995 Feb; 85(2):304-13. PubMed ID: 7824251
[TBL] [Abstract][Full Text] [Related]
5. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
[TBL] [Abstract][Full Text] [Related]
6. Estrogen-progestin replacement therapy and endometrial cancer.
Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
[TBL] [Abstract][Full Text] [Related]
7. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy.
Chubak J; Doherty JA; Cushing-Haugen KL; Voigt LF; Saltzman BS; Hill DA; Beresford SA; Weiss NS
Cancer Causes Control; 2007 Nov; 18(9):1001-7. PubMed ID: 17653829
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone therapy and risk of colorectal cancer.
Johnson JR; Lacey JV; Lazovich D; Geller MA; Schairer C; Schatzkin A; Flood A
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):196-203. PubMed ID: 19124498
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study.
Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck A; Danforth KN; Park Y; Brinton LA
Br J Cancer; 2012 Sep; 107(7):1181-7. PubMed ID: 22929888
[TBL] [Abstract][Full Text] [Related]
10. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
12. Exogenous Hormone Use and Endometrial Cancer in U.S. Black Women.
Sponholtz TR; Palmer JR; Rosenberg LA; Hatch EE; Adams-Campbell LL; Wise LA
Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):558-565. PubMed ID: 29475971
[No Abstract] [Full Text] [Related]
13. Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer.
Doherty JA; Cushing-Haugen KL; Saltzman BS; Voigt LF; Hill DA; Beresford SA; Chen C; Weiss NS
Am J Obstet Gynecol; 2007 Aug; 197(2):139.e1-7. PubMed ID: 17689625
[TBL] [Abstract][Full Text] [Related]
14. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
15. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.
Persson I; Yuen J; Bergkvist L; Schairer C
Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404
[TBL] [Abstract][Full Text] [Related]
16. Risk of endometrial cancer following estrogen replacement with and without progestins.
Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
[TBL] [Abstract][Full Text] [Related]
17. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
18. Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.
McGonigle KF; Karlan BY; Barbuto DA; Leuchter RS; Lagasse LD; Judd HL
Gynecol Oncol; 1994 Oct; 55(1):126-32. PubMed ID: 7959253
[TBL] [Abstract][Full Text] [Related]
19. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
